Parkman Healthcare Partners’s Gilead Sciences GILD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$14.6M	Sell	131,675 -87,275	-40%	-$9.68M	1.68%	20
2025 Q1	$24.5M	Sell	218,950 -155,875	-42%	-$17.5M	2.91%	9
2024 Q4	$34.6M	Buy	374,825 +245,800	+191%	+$22.7M	4.61%	1
2024 Q3	$10.8M	Buy	129,025 +4,025	+3%	+$337K	1.38%	23
2024 Q2	$8.58M	Buy	+125,000	New	+$8.58M	1.15%	33